Navigation Links
TGen President Dr. Jeffrey Trent speaks at Brookings Institution biomedical conference
Date:7/15/2013

WASHINGTON, D.C. July 15, 2013 Dr. Jeffrey Trent, President and Research Director for the Translational Genomics Research Institute (TGen), will discuss state-of-the-art genomics research July 16 at the Brookings Institution.

Dr. Trent, Ph.D., F.A.C.M.G., and former Scientific Director of the National Human Genome Research Institute, is part of a panel, Innovation in Action, at Brookings' 2nd annual State of Biomedical Innovation Conference, which will focus on the use of novel data sources to improve medical product development and care delivery.

Specifically, Dr. Trent will discuss TGen's ongoing work in translating genomics research into clinical benefit. TGen is one of a very few centers who are using the entire human genome in clinical trials in order to diagnose or make treatment decisions for an individual patient (precision medicine).

"The human genome will be the medical textbook for the next century and beyond," Dr. Trent said. "By harnessing the power of the human genome, we will provide immeasurable patient benefit while at the same time reducing the time and costs of diagnosis and treatment. TGen is a global leader in clinical trials that deploy this form of innovative research."

TGen's translational model enables pioneering discoveries in the laboratory to be quickly moved to clinical trials where they can be used to immediately benefit patients with many types of cancer and other debilitating diseases.

Dr. Trent's panel will be moderated by Dr. Mark B. McClellan, Director and Fellow of Brookings' Initiative on Innovation and Value in Health Care. He is the former administrator for the Centers for Medicare and Medicaid Services (2004-2006), and the former commissioner of the Food and Drug Administration (2002-2004). He also served as a member of the President's Council of Economic Advisers, and as senior director for health care policy at the White House (2001-2002). In these positions, he develop
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA
2. Homeland Security Corporation (HSCC) Appoints New President with Biometrics and Access Control Solutions Expertise and Contacts
3. Statement by WCS president and CEO on historic CITES ruling
4. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
5. Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
6. President Obama honors MU researcher with National Medal of Science
7. ONR-funded young innovators recognized by President
8. NASA Goddard scientist receives Presidential Early Career Award
9. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
10. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
11. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... University of Illinois scientists have found compounds that boost ... in a pretty unlikely placethe crushed seeds left after ... fuel. , "The bioactive compounds in Camelina sativa ... a mixture of phytochemicals that work together synergistically ... is a promising nutritional supplement because its bioactive ingredients ...
(Date:9/29/2014)... 2014Research!America,s 19th annual Advocacy Awards ... trailblazers in advancing medical progress to improve the ... event will take place on Wednesday, March 11, ... Washington, DC. , The 2015 Advocacy Award winners ... Michael Milken, founder of the Milken Institute and ...
(Date:9/29/2014)... Department of Energy Joint Genome Institute (DOE JGI), ... announced that 32 new projects have been selected ... sampling Antarctic lakes to Caribbean waters, and from ... water table in forested watersheds, the CSP 2015 ... science can be extracted. , "These projects ...
Breaking Biology News(10 mins):New way to detox? 'Gold of Pleasure' oilseed boosts liver detoxification enzymes 2Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9
... WHO: The American Association of Pharmaceutical Scientists (AAPS) ... members employed in industry, academia, government and other ... a dynamic international forum for the exchange of ... public health. AAPS offers timely scientific programs, on-going ...
... the best way to keep the good bacteria in your ... vitamins, it,s best to get the bacteria you need from ... supplements, says Gail Cresci, Medical College of Georgia dietitian and ... is probably not even helping them and could potentially hurt ...
... is available in French . , Montreal, ... distinguishing between emotions, especially fear and disgust, according to a ... Neuropsychologia . As part of the investigation, Olivier Collignon ... recherche en neuropsychologie et cognition (CERNEC) demonstrated that women are ...
Cached Biology News:Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says 2Eating right, not supplements, is best at keeping your good bacteria healthy, dietitian says 3Women outperform men when identifying emotions 2Women outperform men when identifying emotions 3
(Date:9/30/2014)...  KemPharm, Inc., a clinical-stage specialty pharmaceutical company ... new molecular entity (NME) prodrugs, announced today that ... issued U.S. Patent No. 8,816,083 to KemPharm for ... Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, ... The patent, which extends through 2032, provides ...
(Date:9/30/2014)... 2014 iLab Solutions announced the results ... which focuses on core facility operations, growth and ... face today. , In its 4th year running, a ... is the year-over-year decrease in the percentage of revenue ... be feeling the constraints of this trend. When asked, ...
(Date:9/30/2014)... Lyme Research Alliance (LRA), the nation’s ... universities, today announced the awarding of seven grants worth ... cure for Lyme and other tick-borne diseases. , ... its history—over 20 grant proposals—a 100 percent increase from ... receive so many solid applications from talented scientists this ...
(Date:9/30/2014)... On September 11, Pharma IQ conducted an interview ... a session that he will lead on “Stem Cells” at ... 17-18, 2015 in London. In the interview posted ... to respond to several questions on the current state of ... cell toxicity, and future trends in the use of stem ...
Breaking Biology Technology:KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 2Lyme Research Alliance Awards Nearly $600,000 in New Grants 3Lyme Research Alliance Awards Nearly $600,000 in New Grants 4Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 2Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 3Adult Stem Cell Technology Center, LLC Director James L. Sherley Discusses Stem Cell Toxicology 4
... Net Revenues - a record $35.5 million vs. $24.7 million in Q2 2007 ... - an increase of 43.4%, Q2 2008 Diluted Net Income per Share ... ... in Q2 2007 Q2 2008 New Bookings of $49.0 million vs. $34.5 million in Q2 ...
... F. Finn, Jr.,C.P.A. ("Finn") announced today that the assets ... July 28, 2008 for the benefit of,creditors. An Assignment ... wherein Finn will liquidate the assets, which consist primarily,of ... on October 10, 2008., Persons interested in bidding ...
... to be Called Kowa Pharmaceuticals America, ... Kowa,Company, Ltd., a privately-held company headquartered ... ProEthic Pharmaceuticals, Inc., a,privately-held specialty pharmaceutical company ... 2008, ProEthic will change name to Kowa,Pharmaceuticals ...
Cached Biology Technology:eResearchTechnology Reports Second Quarter 2008 Results 2eResearchTechnology Reports Second Quarter 2008 Results 3eResearchTechnology Reports Second Quarter 2008 Results 4eResearchTechnology Reports Second Quarter 2008 Results 5eResearchTechnology Reports Second Quarter 2008 Results 6eResearchTechnology Reports Second Quarter 2008 Results 7eResearchTechnology Reports Second Quarter 2008 Results 8eResearchTechnology Reports Second Quarter 2008 Results 9Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc. 2
...
HistoScan AP Universal Goat Kit...
Interact with both DNA and RNA; fluorescence green (Em=525 nm) bound to DNA; and fluorescence red (Em=~650 nm) bound to RNA....
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
Biology Products: